Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	300-400
Total Number of Projects:	200-300
2019
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200
2018
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	700-800
Total Number of Projects:	700-800
Networking Rank (Reputation):	100-200
2017
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	300-400
Total Number of Projects:	400-500
Networking Rank (Reputation):	300-400
2016
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	100-200
Total Number of Projects:	200-300
Networking Rank (Reputation):	500-600

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 85
As coordinator: 14
As participant: 64
Sole participant: 7
Coordinator / Participant Ratio: 0.22^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	203.464	43.671.957	3.517.728	1	8
2021	7.832.226	67.809.575	7.484.613	2	13
2020	6.619.072	49.825.857	5.810.830	6	9
2019	22.176.012	102.675.617	13.460.793	4	14
2018	6.527.723	4.250.370	2.055.111	2	2
2017	5.407.488	50.188.027	2.853.901	2	4
2016	18.344.566	62.382.604	10.689.862	4	14

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	13
STICHTING VU	12
JANSSEN PHARMACEUTICA NV	11
KAROLINSKA INSTITUTE	11
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	10
KATHOLIEKE UNIVERSITEIT LEUVEN	10
UNIVERSITEIT GENT	9
ACADEMISCH ZIEKENHUIS GRONINGEN	8
NOVARTIS PHARMA	8
UNIVERSITY COLLEGE LONDON	8
UNIVERSITY OF OSLO	8
REGION HOVEDSTADEN	7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	7
UNIVERSITY OF CAMBRIDGE	7
CHARITE UNIVERSITAETSMEDIZIN BERLIN	6
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	6
KING'S COLLEGE LONDON	6
PFIZER LIMITED	6
STICHTING LYGATURE	6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	6
UNIVERSITE DE GENEVE	6
UNIVERSITY OF HELSINKI	6
VRIJE UNIVERSITEIT BRUSSEL	6
ALZHEIMER EUROPE	5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	5
EUROPEAN CANCER PATIENT COALITION	5
EUROPEAN MOLECULAR BIOLOGY LABORATORY	5
F HOFFMANNLA ROCHE	5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	5
MEDIZINISCHE UNIVERSITAET WIEN	5
TAKEDA DEVELOPMENT CENTRE EUROPE	5
TAKEDA PHARMACEUTICALS INTERNATIONAL	5
THE UNIVERSITY OF NOTTINGHAM	5
UNIVERSITY OF COPENHAGEN	5
UNIVERSITY OF NEWCASTLE UPON TYNE	5
UPPSALA UNIVERSITET	5
VIB VZW	5
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
BAYER	4
CENTRE DE REGULACIO GENOMICA	4
ELI LILLY AND COMPANY LIMITED	4
EUREC OFFICE GUG	4
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	4
MASARYKOVA UNIVERZITA	4
OSPEDALE PEDIATRICO BAMBINO GESU	4
STICHTING RADBOUD UNIVERSITEIT	4
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET	4
TARTU ULIKOOL	4
UNIVERSITAETSKLINIKUM FREIBURG	4
UNIVERSITE DU LUXEMBOURG	4
UNIVERSITEIT MAASTRICHT	4
UNIVERSITY OF BOLOGNA	4
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS	4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	3
CARL ZEISS	3
CELGENE MANAGEMENT SARL	3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
CENTRO DE INVESTIGACION BIOMEDICA EN RED	3
COMMISSARIAT A L'ENERGIE ATOMIQUE	3
CONSIGLIO NAZIONALE DELLE RICERCHE	3
EATRIS ERIC	3
EUROPEAN HEMATOLOGY ASSOCIATION	3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA	3
GMV SOLUCIONES GLOBALES INTERNET SAU	3
GOETEBORGS UNIVERSITET	3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	3
H LUNDBECK AS	3
LEIDEN UNIVERSITY	3
LEIDS UNIVERSITAIR MEDISCH CENTRUM	3
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE	3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	3
NATIONAL TECHNICAL UNIVERSITY OF ATHENS	3
NOVO NORDISK	3
OSLO UNIVERSITETSSYKEHUS HF	3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI	3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG	3
SANOFIAVENTIS	3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	3
TERVEYDEN JA HYVINVOINNIN LAITOS	3
THE UNIVERSITY OF EDINBURGH	3
THE UNIVERSITY OF MANCHESTER	3
UNIVERSIDAD DE NAVARRA	3
UNIVERSITA CATTOLICA DEL SACRO CUORE	3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA	3
UNIVERSITA DEGLI STUDI DI TORINO	3
UNIVERSITAET ULM	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	3
UNIVERSITATSKLINIKUM BONN	3
UNIVERSITEIT UTRECHT	3
UNIVERZA V LJUBLJANI	3
UNIWERSYTET JAGIELLONSKI	3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER	3
ABBVIE INC	2
ACADEMISCH ZIEKENHUIS LEIDEN	2
AGE PLATFORM EUROPE	2

Constancy:

Total number of partners: 1197
Partner loyalty:
Frequent Partner: (> 2 projects): 451
Rare Partner: 746
Frequent / Rare Partner Ratio: 0.6

Project overview:

Start date	Project	acronym	role	funding	partners
2022-10-01	improving Research Ethics Expertise and Competences to Ensure Reliability and Trust in Science	iRECS	participant	3.794.374	18
2022-09-01	Pro-active Pandemic Crisis Ethics and Integrity Framework	PREPARED	participant	4.201.759	16
2022-09-01	Moral residue - epistemological ramifications, ethical implications and didactic opportunities	MORE	participant	2.455.263	4
2022-09-01	Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and their Family Caregivers: an international pragmatic randomized controlled trial	EU NAVIGATE	participant	5.993.222	12
2022-09-01	A PeRsOnalized Prevention roadmap for the future HEalThcare	PROPHET	participant	2.812.437	20
2022-08-01	INnoVAtive Solution for Imaging of Infiltrating mONocytes	INVASIION	coordinator	203.464	1
2022-07-01	eBRAIN-Health - Actionable Multilevel Health Data	eBRAIN-Health	participant	12.436.805	20
2022-06-01	RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY	CANCERNA	participant	5.999.381	13
2022-05-01	VALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERY	CLASSICA	participant	5.978.716	11
2021-11-01	European platform for neurodegenerative disorders	EPND	participant	9.680.000	29
2021-10-01	Beyond COVID	BY-COVID	participant	12.000.000	53
2021-07-01	PI3K/PTEN-related monogenic disease to understand cancer	PIPgen	participant	4.099.075	11
2021-06-01	Psychiatric Ratings using Intermediate Stratified Markers 2	PRISM 2	participant	3.980.906	15
2021-06-01	Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes	I-CARE4OLD	coordinator	5.832.536	14
2021-04-01	Tau Pathology in Alzheimer’s disease: Spreading and Resilience	TAU-NOW	participant	1.500.000	2
2021-04-01	POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment	POLYRISK	participant	5.991.078	15
2021-04-01	Non-coding RNA and Intercellular Communication in Cardiac Ageing	NICCA	coordinator	1.999.690	1
2021-03-01	A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis	GLYTUNES	participant	3.744.224	11
2021-03-01	Training Network for Optimizing Adoptive T cell Therapy of Cancer	T-OP	participant	4.100.959	12
2021-03-01	Anti-Cancer Light-Controllable Antibody-Peptide Conjugates	ALISE	participant	745.200	7
2021-02-01	Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine	TIGER	participant	6.900.000	8
2021-01-01	Evidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion.	Health CASCADE	participant	4.058.109	7
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2021-01-01	Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy	T2EVOLVE	participant	8.728.185	29
2020-12-01	Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic	RESPOND	participant	6.172.028	17
2020-11-01	Drug discovery screening using human neurons	HumanNeuronScreen	coordinator	150.000	1
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	41
2020-10-01	Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration	SkinTERM	participant	3.192.736	9
2020-07-01	Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).	Impentri	participant	3.662.963	5
2020-06-01	Beyond 1M Genomes	B1MG	participant	4.000.000	37
2020-06-01	Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature	AngioCAR	coordinator	175.572	1
2020-05-01	Molecular Imaging of Microglia	MIM	coordinator	175.572	1
2020-04-01	Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity	EDUC8	participant	2.100.702	9
2020-02-01	Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells	UNPACK PD-L1	coordinator	175.572	1
2020-01-01	EXposome Powered tools for healthy living in urbAN SEttings	EXPANSE	participant	11.993.907	20
2020-01-01	Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity	EarlyCause	participant	5.997.381	14
2020-01-01	Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research	MATCH	coordinator	150.000	1
2020-01-01	A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities	TO_AITION	participant	5.990.515	14
2020-01-01	RISK-BASED SCREENING FOR CERVICAL CANCER	RISCC	coordinator	5.792.355	11
2019-11-01	Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis	MIRIADE	coordinator	4.015.376	11
2019-10-01	Exploitation of the SECRETory pathway for cancer therapy to address European research	SECRET	participant	3.915.872	12
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	coordinator	15.000.000	23
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-06-01	Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis	Host-TB	coordinator	2.160.926	2
2019-06-01	Research and Training in Early Life Nutrition to Prevent Disease	GROWTH	participant	2.133.199	8
2019-05-01	ENdoThelial macRophage Alliance In Neuroinflammation	ENTRAIN	participant	3.664.174	20
2019-05-01	Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)	DISTINCT	participant	3.998.048	10
2019-05-01	Saracatinib Trial tO Prevent FOP	STOPFOP	coordinator	999.710	6
2019-03-01	European network staff eXchange for integrAting precision health in the health Care sysTems	ExACT	participant	1.090.200	18
2019-01-01	CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease	CardioReGenix	participant	14.839.774	13

overview shows latest 50 from 85 projects (2016-01-01 - 2022-12-31)
A full list of projects can be found here:

STICHTING VUMC -